A 1540 nm Erbium:glass laser offers non-ablative, deep dermal treatment for facial and back acne. By targeting water in the dermis, it creates controlled microthermal injury that can remodel collagen and temporarily suppress sebaceous gland activity while preserving the epidermal surface. Clinical evaluations report approximately 78% to 82% reductions in acne lesion counts after a course of treatments, with improvement sustained for as long as two years in reported follow-up.
The 1540 nm Erbium:glass laser combines meaningful acne clearance with low downtime, reduced skin oiliness, and a favorable safety profile across Fitzpatrick skin Types I–IV. Its non-ablative design and ability to treat large areas make it particularly useful for both facial and truncal acne.
How the 1540 nm Erbium:glass Laser Works
Non-ablative dermal heating
The system delivers infrared energy into the dermis, where it is absorbed primarily by water. This produces controlled thermal injury below the skin surface without removing or vaporizing the epidermis.
The resulting microthermal zones initiate a wound-healing response that promotes collagen remodeling and gradual dermal reorganization.
Sebaceous gland modulation
Thermal energy reaches the pilosebaceous unit and can temporarily alter sebaceous gland function. This reduces oiliness, an important factor in the development and persistence of acne lesions.
Some clinical and biopsy findings also describe longer-term sebaceous gland miniaturization or rarefaction after treatment, although the extent of this effect depends on the treatment protocol and patient response.
Deep treatment with preserved surface skin
Reported penetration depths are approximately 0.4 mm to 2.0 mm, allowing treatment of dermal structures while leaving the outer epidermis intact. This distinguishes the technology from ablative resurfacing systems that deliberately remove surface tissue.
Performance Features for Clinical Practice
Treatment of the face and back
The 1540 nm wavelength can be used on both facial and truncal acne, including the back and chest. Its ability to cover larger anatomical areas makes it practical for patients whose acne extends beyond the face.
Back acne can be difficult to manage with topical products because of the area’s size and limited patient reach. A laser platform that treats larger surfaces can therefore support a more efficient in-office workflow.
Contact cooling for comfort
Many systems incorporate sapphire or other contact cooling to protect the epidermis during energy delivery. Cooling can reduce treatment discomfort while allowing thermal energy to reach the deeper target structures.
With effective surface cooling, protocols may be performed with little or no topical anesthesia. This can improve patient tolerance and reduce the logistical burden of treatment.
Limited downtime
Because the procedure is non-ablative, the epidermis remains substantially intact. Patients may experience temporary redness, warmth, swelling, or sensitivity, but the recovery period is generally shorter than that associated with ablative resurfacing.
This profile can make the treatment easier to integrate into the schedules of patients who cannot accommodate prolonged visible recovery.
Compatibility with varied skin phototypes
Clinical evaluations have reported efficacy across Fitzpatrick skin Types I–IV. The wavelength has relatively low melanin absorption compared with shorter-wavelength treatments, which may reduce the risk of epidermal pigment injury.
However, lower melanin absorption does not eliminate pigment-related risk. Patient selection, cooling, energy settings, sun exposure, and post-treatment care remain important, particularly for darker or recently tanned skin.
What Clinical Results Can Patients Expect?
Reduction in active lesions
Across reported clinical evaluations, four treatments delivered at biweekly or monthly intervals have produced approximately 78% to 82% reductions in acne lesion counts. Improvements have included inflammatory lesions such as papules, pustules, and deeper nodules.
Other protocols report lower or broader response ranges, including approximately 70% to 78% improvement. Results vary according to acne severity, treatment settings, follow-up duration, and how lesions are counted.
Improvement in skin oiliness
Patients commonly report a noticeable reduction in cutaneous oiliness after treatment. This may contribute to fewer new lesions and can improve the overall feel and appearance of acne-prone skin.
The reduction in sebum should be viewed as a treatment benefit rather than a guarantee of permanent sebaceous gland suppression.
Durability of clearance
Reported follow-up indicates that acne clearance can remain sustained for up to two years after treatment in some patients. This suggests that the treatment may produce more than a short-lived reduction in visible inflammation.
Long-term results are not necessarily permanent for every patient. Acne biology, hormonal influences, skincare, and maintenance treatment can affect the durability of response.
Potential textural benefits
The dermal remodeling response may also improve pore appearance and atrophic acne-scar texture. These textural effects are related to collagen remodeling and may develop gradually rather than immediately after the procedure.
Treatment should still be selected according to the patient’s primary concern. Active acne control and acne-scar resurfacing may require different settings, treatment schedules, or complementary therapies.
Why the Technology Fits Facial and Back Acne
Addresses deeper acne drivers
Topical medications primarily act at the skin surface and within the follicular opening. The 1540 nm system reaches dermal targets associated with inflammation and sebaceous gland activity.
This makes it a useful option when acne is persistent, inflammatory, widespread, or difficult to manage with topical treatment alone.
Treats broad surfaces efficiently
The back and chest contain large areas with numerous follicles and sebaceous glands. A system designed for dermal treatment across broad surfaces can be more practical than lesion-by-lesion approaches.
This is particularly relevant for patients with simultaneous facial and truncal disease.
Balances efficacy and tolerability
The system is designed to deliver meaningful thermal treatment while protecting the epidermis. Contact cooling and non-ablative delivery can reduce pain and downtime compared with some other infrared laser modalities.
Patient comfort remains dependent on the device, settings, treatment area, and individual sensitivity.
Understanding the Trade-offs
Results require a treatment series
The strongest reported outcomes generally follow a series of approximately four treatments, often spaced two weeks apart or delivered monthly. Patients should not expect the full response after a single session.
A complete treatment plan should include realistic expectations about the time needed for inflammation, oiliness, and collagen remodeling to improve.
Efficacy is not uniform
Reported outcomes range from moderate improvement to reductions approaching 80% or more. Differences in device parameters, acne severity, lesion-counting methods, and follow-up periods make direct comparison between studies difficult.
Clinical claims should therefore be presented as expected ranges rather than guaranteed results.
Pigment risk is reduced, not eliminated
The 1540 nm wavelength is relatively sparing of epidermal melanin, and reported studies describe a low risk of post-inflammatory hyperpigmentation. Nevertheless, darker or tanned skin can still develop pigment changes after thermal injury.
Careful parameter selection, strict sun avoidance, cooling, and appropriate aftercare remain necessary.
Acne may recur
Sebaceous gland modulation and long-term improvement do not ensure permanent remission. Patients may still need skincare, medical acne therapy, hormonal management, or maintenance laser treatments.
The laser should be considered part of a comprehensive acne strategy when clinically appropriate.
How to Apply This to Patient Selection
The best candidates are patients with active inflammatory acne who want a non-ablative procedure with limited downtime and who may have disease across both facial and truncal areas.
- If your primary focus is active facial acne: Use the 1540 nm Erbium:glass laser as a course-based treatment aimed at reducing inflammatory lesions and oiliness while preserving the epidermal surface.
- If your primary focus is back or chest acne: Consider the system’s broad-area treatment capability as a practical advantage for widespread truncal disease.
- If your primary focus is patient comfort: Prioritize platforms with integrated contact cooling and protocols that can minimize or avoid topical anesthesia.
- If your primary focus is treating diverse skin phototypes: Use the reported safety advantage of relatively low melanin absorption, while retaining conservative settings and careful pigment-risk management.
- If your primary focus is long-term control: Explain that sustained improvement has been reported for up to two years, but maintenance care may still be necessary.
A 1540 nm Erbium:glass laser is a clinically useful non-ablative option when acne clearance, oil reduction, broad-area treatment, and limited downtime are all important goals.
Summary Table:
| Feature | Details |
|---|---|
| Wavelength | 1540 nm (infrared) |
| Mechanism | Non-ablative, heats dermis |
| Target | Water in dermis, sebaceous glands |
| Lesion Reduction | 78%-82% decrease after 4 sessions |
| Downtime | Minimal, few days of redness/swelling |
| Skin Types | Fitzpatrick I-IV |
| Treatment Areas | Face, back, chest |
| Results | Up to 2 years sustained |
| Comfort | Contact cooling, minimal pain |
Are you ready to offer your patients effective, non-ablative acne treatment? At BELIS, we specialize in professional-grade medical aesthetic equipment exclusively for clinics and premium salons. Our 1540nm Erbium:glass laser systems are engineered for superior performance and safety, delivering proven results for facial and back acne. Join leading clinics and spas that trust BELIS for advanced laser technology, including Diode, Alexandrite, CO2, Erbium, Nd:YAG, Pico, and our 1540nm Erbium:glass laser. Enhance your practice with our cutting-edge devices and comprehensive support. Contact us today to learn more about partnership opportunities and elevate your aesthetic offerings.
Related Products
- 9D 7D HIFU Vaginal RF Lifting Treatment
- Professional Face and Vaginal 7D HIFU System for HIFU Clinic Treatments
People Also Ask
- Is HIFU treatment considered safe and what are the potential risks? A Guide to Safe Non-Invasive Skin Tightening
- Is a HIFU treatment painful? Discover Comfort Levels and Results for Non-Surgical Lifting
- How does HIFU treatment differ from other skin tightening procedures? Compare Non-Invasive Lifting vs. Surgery
- What are the primary benefits of HIFU treatment? Reveal a Youthful V-Line and Firm Skin Non-Invasively
- Why are HIFU systems equipped with multiple treatment handpieces? Precision Depth Control for Superior Skin Results
